Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes.
Wagner R, Heni M, Tabák AG, Machann J, Schick F, Randrianarisoa E, Hrabě de Angelis M, Birkenfeld AL, Stefan N, Peter A, Häring HU, Fritsche A.
Wagner R, et al.
Nat Med. 2021 Jan;27(1):49-57. doi: 10.1038/s41591-020-1116-9. Epub 2021 Jan 4.
Nat Med. 2021.
PMID: 33398163